Effect of Manual Chest Wall Vibration on Respiratory Function and Chest Tube Duration After Thoracic Surgery
The Effect of Manual Chest Wall Vibration on Respiratory Functions and Chest Tube Duration in Patients Undergoing Thoracic Surgery
1 other identifier
interventional
60
1 country
1
Brief Summary
This study was conducted to determine the effects of a manual vibration technique applied to the chest wall on the duration of chest tube placement, secretion clearance, and hemodynamic parameters in patients with chest tubes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 16, 2026
CompletedFirst Posted
Study publicly available on registry
April 24, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedApril 24, 2026
April 1, 2026
6 months
April 16, 2026
April 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient Follow-Up Form
Changes in respiratory and hemodynamic parameters (including respiratory rate, peripheral oxygen saturation, heart rate, blood pressure), dyspnea severity (Modified Borg Scale), and pain intensity (Visual Numeric Rating Scale) measured before the intervention and at 0, 1, 5, 10, and 15 minutes after the intervention.
1 day
Secondary Outcomes (2)
Post-Operative Respiratory Status Questionnaire
1 day
Questionnaire on manual chest wall vibration therapy
1 day
Study Arms (2)
Chest Wall Oscillation Group
ACTIVE COMPARATORPostoperative patients with chest tubes received manual chest wall vibration in addition to routine nursing care twice daily (morning and evening). Before the intervention, patients were informed and provided written consent. Baseline measurements included dyspnea (Modified Borg Scale), pain (VNRS), vital signs, and arterial blood gas values. The intervention was performed in semi-Fowler's position during the expiratory phase, applying gentle vibrations from lower to upper lobes for approximately 5 minutes (10 breathing cycles). Patients were guided to use slow nasal inhalation and pursed-lip exhalation. Outcomes were reassessed at 3rd, 5th, and 10th minutes after the intervention. The same procedure was repeated in the evening, and all data were recorded.
Conventional Control Group
SHAM COMPARATORControl group patients were informed about the study and provided written consent. They received only routine nursing care without any additional intervention. At baseline (0 min), Patient Identification and Follow-up Forms were completed. Dyspnea was assessed using the Modified Borg Scale (MBS), pain using the Visual Numeric Rating Scale (VNRS), and vital signs and arterial blood gas values were recorded. Following routine care, measurements of vital signs, blood gases, dyspnea, and pain were repeated at 0, 3, 5, and 10 minutes and documented. Unlike the intervention group, no manual chest wall vibration was applied, and standard clinical follow-up was maintained. The same monitoring and recording procedures were repeated in the evening session.
Interventions
Manual chest wall vibration is applied with the patient in a semi-Fowler's position during the expiratory phase of breathing. The practitioner places both hands flat on the chest wall and delivers gentle, rhythmic vibrations, starting from the lower lobes and progressing toward the upper lobes. Patients are instructed to inhale slowly through the nose and exhale using a pursed-lip breathing technique with a 1:2 inspiration-expiration ratio. The procedure is performed for approximately 5 minutes, corresponding to about 10 respiratory cycles, and is typically applied during the patient's rest period following routine care.
Control group patients were informed about the study and provided written consent. They received only routine nursing care, with no additional interventions applied. Baseline measurements were taken at 0 minutes, including dyspnea (MBS), pain (VNRS), vital signs, and arterial blood gas values. Following routine care, the same parameters were reassessed at 3, 5, and 10 minutes and recorded. No manual chest wall vibration was performed; only standard clinical monitoring was maintained. The same assessment protocol was repeated in the evening session.
Eligibility Criteria
You may qualify if:
- Having undergone thoracic surgery
- Having a chest tube in the postoperative period
- Being hemodynamically stable
- Agreeing to participate in the study
- Being open to communication and cooperation
You may not qualify if:
- Severe cardiac instability
- Patients unable to tolerate the procedure due to neurological or cognitive impairment
- Clinical conditions that would prevent the application of vibration to the chest wall
- Patients diagnosed with pneumonia
- Patients with a newly implanted transvenous or subcutaneous pacemaker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Health Sciences, Saglik Bilimleri University
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Sibel YILMAZ SAHİN, Assoc Prof
Institute of Health Sciences, Saglik Bilimleri University
- PRINCIPAL INVESTIGATOR
Beyza SU, MSc.
Institute of Health Sciences, Saglik Bilimleri University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Conventional control group will have regular nursing cares and outcome assessments will be performed by a investigator who was blinded to group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MSc., Nurse
Study Record Dates
First Submitted
April 16, 2026
First Posted
April 24, 2026
Study Start
October 1, 2025
Primary Completion
April 1, 2026
Study Completion
May 1, 2026
Last Updated
April 24, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share